This paper is in the following e-collection/theme issue:

Design and Usability of Clinical Software and EHRs (286) Public (e)Health, Digital Epidemiology and Public Health Informatics (825) JMIR Theme Issue: COVID-19 Special Issue (2479)

Published on in Vol 9, No 4 (2022): Oct-Dec

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/38701, first published .
A Mobile App Leveraging Citizenship Engagement to Perform Anonymized Longitudinal Studies in the Context of COVID-19 Adverse Drug Reaction Monitoring: Development and Usability Study

A Mobile App Leveraging Citizenship Engagement to Perform Anonymized Longitudinal Studies in the Context of COVID-19 Adverse Drug Reaction Monitoring: Development and Usability Study

A Mobile App Leveraging Citizenship Engagement to Perform Anonymized Longitudinal Studies in the Context of COVID-19 Adverse Drug Reaction Monitoring: Development and Usability Study

Authors of this article:

Marzia Di Filippo1 Author Orcid Image ;   Alessandro Avellone1 Author Orcid Image ;   Michael Belingheri2 Author Orcid Image ;   Maria Emilia Paladino2 Author Orcid Image ;   Michele Augusto Riva2 Author Orcid Image ;   Antonella Zambon1 Author Orcid Image ;   Dario Pescini1 Author Orcid Image
Article Authors Cited by (3) Tweetations (2) Metrics

Journals

  1. Zang S, Zhang X, Xing Y, Chen J, Lin L, Hou Z. Applications of Social Media and Digital Technologies in COVID-19 Vaccination: Scoping Review. Journal of Medical Internet Research 2023;25:e40057 View
  2. Olsavszky V, Bazari M, Dai T, Olsavszky A, Finkelmeier F, Friedrich-Rust M, Zeuzem S, Herrmann E, Leipe J, Michael F, Westernhagen H, Ballo O. Digital Translation Platform (Translatly) to Overcome Communication Barriers in Clinical Care: Pilot Study. JMIR Formative Research 2025;9:e63095 View
  3. Dedefo M, Lim R, Kassie G, Gebreyohannes E, Salekdeh N, Roughead E, Kalisch Ellett L. Consumer views on the use of digital tools for reporting adverse drug reactions: a cross-sectional study. International Journal of Clinical Pharmacy 2024 View